Pharmacotherapy for Treatment-Resistant Depression
Psychiatric Clinics of North America · 2023
DOI: 10.1016/j.psc.2023.02.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatric Clinics of North America, 2023. Verfasst von Collin Vas und 4 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Antipsychotic Agents, Major Depressive Disorder. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UT Southwestern Medical Center, Dallas, TX, USA.
- The Shri Ram School, Aravali, Gurgaon, Haryana, India.
- Colleyville Heritage High School, Colleyville, TX, USA.
- Center for Depression Research and Clinical Care, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9119, USA. Electronic address: manish.jha@utsouthwestern.edu.
- Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, The Menninger Clinic, Houston, TX, USA.
Zitieren
APA
Vas, C., Jain, A., Trivedi, M., Jha, M. K., & Mathew, S. J. (2023). Pharmacotherapy for Treatment-Resistant Depression. Psychiatric Clinics of North America. https://doi.org/10.1016/j.psc.2023.02.012
Vancouver
Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ. Pharmacotherapy for Treatment-Resistant Depression. Psychiatric Clinics of North America. 2023. doi:10.1016/j.psc.2023.02.012
BibTeX
@article{Vas2023,
author = {Vas, Collin and Jain, Ayush and Trivedi, Mili and Jha, Manish Kumar and Mathew, Sanjay J},
title = {Pharmacotherapy for Treatment-Resistant Depression},
journal = {Psychiatric Clinics of North America},
year = {2023},
doi = {10.1016/j.psc.2023.02.012}
}
EUVIMED